• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在具有临床挑战性的情况下使用阿片类药物治疗疼痛:临床医生的问题。

Using opioid therapy for pain in clinically challenging situations: questions for clinicians.

机构信息

NEMA Research, Inc., Naples, FL, USA.

NEMA Research, Inc., Naples, FL, USA -

出版信息

Minerva Anestesiol. 2019 Aug;85(8):899-908. doi: 10.23736/S0375-9393.19.13321-4. Epub 2019 Mar 12.

DOI:10.23736/S0375-9393.19.13321-4
PMID:30871302
Abstract

Healthcare professionals and organizations increasingly face the conundrum of treating patients with active substance use disorder, a history of personal or familial substance use disorder, or those at elevated risk for substance abuse. Such patients need compassionate care when facing painful conditions; in fact, denying them pain control makes it likely that they will seek out ways to self-medicate with illicit drugs. Yet it remains unclear how to safely and effectively treat patients in these challenging situations. The authors have formulated ten questions to address in order to provide adequate analgesia for such patients. These questions demand a highly individualized approach to analgesia. These ten questions involve understanding the painful condition (presumed trajectory, duration, type of pain), using validated metrics such as risk assessment tools, guidelines, protocols, and safeguards within the system, selection of the optimal analgesic product(s) or combination therapy, and never starting opioid therapy without clear treatment objectives and a definitive exit plan. It is tempting but inaccurate to label these individuals as "inappropriate patients," rather they are high-risk individuals in very challenging clinical situations. The challenge is that both options - being in pain or being treated with opioids to control pain - expose the patient to a risk of rekindling an addiction. The question is how do we, as clinicians, adequately respond to these very perplexing clinical challenges?

摘要

医疗保健专业人员和组织越来越面临这样的困境

治疗有物质使用障碍、个人或家族物质使用障碍史或有物质滥用高风险的患者。当这些患者面临痛苦的病情时,他们需要得到富有同情心的护理;事实上,拒绝为他们提供疼痛控制很可能会导致他们寻求非法药物来自我治疗。然而,目前仍不清楚如何在这些具有挑战性的情况下安全有效地治疗这些患者。作者提出了十个问题,以提供足够的镇痛治疗。这些问题需要对镇痛进行高度个体化的治疗。这十个问题涉及了解疼痛情况(假定的轨迹、持续时间、疼痛类型),使用风险评估工具等经过验证的指标,系统内的指南、方案和保障措施,选择最佳的镇痛产品或联合治疗,并且在没有明确的治疗目标和明确的退出计划的情况下,切勿开始阿片类药物治疗。将这些患者贴上“不适当患者”的标签是诱人的,但却是不准确的,他们是处于非常具有挑战性的临床情况下的高风险个体。挑战在于,无论是处于疼痛状态还是用阿片类药物来控制疼痛,都会使患者面临重新上瘾的风险。问题是,作为临床医生,我们如何应对这些非常令人困惑的临床挑战?

相似文献

1
Using opioid therapy for pain in clinically challenging situations: questions for clinicians.在具有临床挑战性的情况下使用阿片类药物治疗疼痛:临床医生的问题。
Minerva Anestesiol. 2019 Aug;85(8):899-908. doi: 10.23736/S0375-9393.19.13321-4. Epub 2019 Mar 12.
2
The prescription opioid conundrum: 21st century solutions to a millennia-long problem.处方类阿片类药物的困境:千年问题的 21 世纪解决方案。
Postgrad Med. 2020 Jan;132(1):17-27. doi: 10.1080/00325481.2019.1677383. Epub 2019 Oct 20.
3
Addressing the Opioid Crisis: Medical Student Instruction in Opioid Drug Pharmacology, Pain Management, and Substance Use Disorders.应对阿片类药物危机:医学学生在阿片类药物药理学、疼痛管理和物质使用障碍方面的教学。
J Pharmacol Exp Ther. 2019 Nov;371(2):500-506. doi: 10.1124/jpet.119.257329. Epub 2019 Jul 18.
4
Chronic pain management in dermatology: pharmacotherapy and therapeutic monitoring with opioid analgesia.皮肤科慢性疼痛管理:阿片类镇痛药的药物治疗和治疗监测。
J Am Acad Dermatol. 2015 Oct;73(4):575-82; quiz 583-4. doi: 10.1016/j.jaad.2014.11.038.
5
The price of pain. Physicians cite need for better communication to successfully treat pain and monitor for possible abuse.疼痛的代价。医生们指出需要更好的沟通来成功治疗疼痛并监测可能的药物滥用情况。
Med Econ. 2013 Mar 10;90(5):30, 32, 39.
6
Pain Control in the Presence of Drug Addiction.药物成瘾情况下的疼痛控制
Curr Pain Headache Rep. 2016 May;20(5):35. doi: 10.1007/s11916-016-0561-0.
7
Opioid addiction and misuse in adult and adolescent patients with cancer.癌症成年和青少年患者中的阿片类药物成瘾及滥用问题
Intern Med J. 2017 Jun;47(6):632-636. doi: 10.1111/imj.13449.
8
Opioid therapy in patients with chronic noncancer pain: diagnostic and clinical challenges.慢性非癌性疼痛患者的阿片类药物治疗:诊断和临床挑战
Adv Psychosom Med. 2011;30:61-91. doi: 10.1159/000324067. Epub 2011 Apr 19.
9
Opioid therapy in chronic pain.慢性疼痛中的阿片类药物治疗
Phys Med Rehabil Clin N Am. 2015 May;26(2):201-18. doi: 10.1016/j.pmr.2014.12.001. Epub 2015 Feb 14.
10
American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.美国介入性疼痛医师学会(ASIPP)慢性非癌痛患者阿片类药物负责任处方指南:第 2 部分——指南。
Pain Physician. 2012 Jul;15(3 Suppl):S67-116.

引用本文的文献

1
Pain Management in Cancer Patients With Artificial Intelligence: Narrative Review.人工智能在癌症患者疼痛管理中的应用:叙述性综述
Scientifica (Cairo). 2025 Apr 22;2025:6888213. doi: 10.1155/sci5/6888213. eCollection 2025.
2
Prevention of Opioid Misuse and Abuse Through Effective Pain Management in Patients With Chronic Pain: An Umbrella Systematic Review.通过对慢性疼痛患者进行有效的疼痛管理预防阿片类药物的误用和滥用:一项伞形系统评价
Cureus. 2025 Mar 20;17(3):e80906. doi: 10.7759/cureus.80906. eCollection 2025 Mar.
3
A Machine Learning Application to Classify Patients at Differing Levels of Risk of Opioid Use Disorder: Clinician-Based Validation Study.
一种用于对阿片类物质使用障碍不同风险水平患者进行分类的机器学习应用:基于临床医生的验证研究。
JMIR Med Inform. 2024 Jun 4;12:e53625. doi: 10.2196/53625.
4
A Randomized Controlled Trial of a Novel Formulation of Ketorolac Tromethamine for Continuous Infusion (NTM-001) in Healthy Volunteers.一项新型酮咯酸氨丁三醇持续输注制剂(NTM-001)在健康志愿者中的随机对照试验。
Adv Ther. 2024 Feb;41(2):659-671. doi: 10.1007/s12325-023-02709-5. Epub 2023 Dec 9.
5
Chronic Pain after Bone Fracture: Current Insights into Molecular Mechanisms and Therapeutic Strategies.骨折后的慢性疼痛:分子机制与治疗策略的当前见解
Brain Sci. 2022 Aug 9;12(8):1056. doi: 10.3390/brainsci12081056.
6
Current and Future Therapeutic Options in Pain Management: Multi-mechanistic Opioids Involving Both MOR and NOP Receptor Activation.当前和未来的疼痛管理治疗选择:涉及 MOR 和 NOP 受体激活的多机制阿片类药物。
CNS Drugs. 2022 Jun;36(6):617-632. doi: 10.1007/s40263-022-00924-2. Epub 2022 May 26.
7
Safe Use of Opioids in Chronic Kidney Disease and Hemodialysis Patients: Tips and Tricks for Non-Pain Specialists.慢性肾脏病和血液透析患者阿片类药物的安全使用:非疼痛专科医生的实用技巧
Ther Clin Risk Manag. 2020 Sep 9;16:821-837. doi: 10.2147/TCRM.S262843. eCollection 2020.
8
What to Do and What Not to Do in the Management of Opioid-Induced Constipation: A Choosing Wisely Report.阿片类药物所致便秘管理中的注意事项:明智选择报告
Pain Ther. 2020 Dec;9(2):657-667. doi: 10.1007/s40122-020-00195-z. Epub 2020 Sep 17.